Quest Diagnostics Incorporated vs Agilent Technologies, Inc.
A head-to-head of Quest Diagnostics Incorporated (DGX) and Agilent Technologies, Inc. (A) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | DGX | A |
|---|---|---|
| Market Cap | $23.32B | $37.13B |
| P/E (TTM) | 23.28 | 26.40 |
| Forward P/E | 18.05 | 20.45 |
| P/S | 1.91 | 4.47 |
| P/B | 4.41 | 5.21 |
| EV/EBITDA | 12.50 | 17.27 |
| Dividend Yield | 1.05% | 0.77% |
| Profit Margin | 9.08% | 19.55% |
| Gross Margin | 33.21% | 52.43% |
| Operating Margin | 14.10% | 21.29% |
| Revenue Growth (YoY) | +9.16% | +10.01% |
| FCF Yield | 6.14% | 3.36% |
| Debt / Equity | 73.05 | 47.11 |
| Current Ratio | 1.18 | 2.10 |
Which is better: Quest Diagnostics Incorporated or Agilent Technologies, Inc.?
- ✓Larger by market cap: Agilent Technologies, Inc.
- ✓Cheaper valuation (lower P/E): Quest Diagnostics Incorporated
- ✓Higher dividend yield: Quest Diagnostics Incorporated
- ✓More profitable (net margin): Agilent Technologies, Inc.
- ✓Faster revenue growth: Agilent Technologies, Inc.
- ✓Higher free-cash-flow yield: Quest Diagnostics Incorporated
Across 13 available metrics, Quest Diagnostics Incorporated leads 7–6.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.